Markedly elevated serum IL-6 levels predict relapse within six months of treatment initiation in Still's disease.

IF 3.4 4区医学 Q2 RHEUMATOLOGY

Clinical and experimental rheumatology Pub Date : 2024-10-01 Epub Date: 2024-09-03 DOI:10.55563/clinexprheumatol/611dkl

Hideki Oka, Shuji Sumitomo, Hayato Shimizu, Koichiro Ohmura

引用次数: 0

查看原文本刊更多论文

血清 IL-6 水平明显升高预示着斯蒂尔病在开始治疗后六个月内会复发。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and experimental rheumatology 医学-风湿病学

CiteScore

6.10

自引率

18.90%

发文量

377

审稿时长

3-6 weeks

期刊介绍： Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.